Georgia
http://www.ganet.org/cgi-bin/pub/ocode/ocgsearch?docname=OCode/G/16/13/71&highlight=nitrous
(a) A "dangerous drug" means any drug other than a drug contained in
any schedule of Article 2 of this chapter, which, under the Federal
Food, Drug, and Cosmetic Act (52 Stat. 1040 (1938)), 21 U.S.C.
Section 301, et seq., as amended, may be dispensed only upon
prescription. In any civil or criminal action or other proceedings,
a certification from the Food and Drug Administration of the United
States Department of Health and Human Services attesting to the fact
that a drug other than a drug contained in any schedule of Article 2
of this chapter involved in the action or proceeding is a dangerous
drug that federal law prohibits dispensing of without a prescription
pursuant to the Federal Food, Drug, and Cosmetic Act shall be
admissible as prima-facie proof that such drug is a "dangerous
drug."
(b) In addition to subsection (a) of this Code section, a "dangerous
drug" means any other drug or substance declared by the General
Assembly to be a dangerous drug; to include any of the following
drugs, chemicals, or substances; salts, isomers, esters, ethers, or
derivatives of such drugs, chemicals, or substances which have
essentially the same pharmacological action; all other salts,
isomers, esters, ethers, and compounds of such drugs, chemicals, or
substances unless specifically exempted and the following devices,
identified as "dangerous drugs": (lists a TON of stuff……..)
648.3) Nitrous oxide -- See exceptions;
16) Nitrous oxide -- air products suppliers shall not sell
medical grade nitrous oxide to other than licensed practitioners
or medical suppliers; industrial grade nitrous oxide shall only be
sold when mixed with not less than 100 parts per million of sulfur
dioxide and used as a fuel additive for combustion
(e) The State Board of Pharmacy may delete drugs from the dangerous
drug list set forth in this Code section. In making such deletions
the board shall consider, with respect to each drug, the following
factors:
(1) The actual or relative potential for abuse;
(2) The scientific evidence of its pharmacological effect, if
known;
(3) The state of current scientific knowledge regarding the drug;
(4) The history and current pattern of abuse, if any;
(5) The scope, duration, and significance of abuse;
(6) Reserved;
(7) The potential of the drug to produce psychic or physiological
dependence liability; and
(8) Whether such drug is included under the Federal Food, Drug,
and Cosmetic Act, 52 Stat. 1040 (1938), 21 U.S.C. Section 301, et
seq., as amended.